Table 1.
Participant characteristics.
| Patient Characteristics | (N = 200) |
|---|---|
| Age in years, mean (SD) | 74 (SD 6.8) |
| Gender | |
| Female, n (%) | 146 (73.0) |
| Preferred language | |
| Spanish, n (%) | 186 (93.0) |
| English, n (%) | 14 (7.0) |
| Hispanic, n (%) | 186 (93.0) |
| Race | |
| Black/African American, n (%) | 11 (5.5) |
| White, n (%) | 32 (16.0) |
| Multiracial, n (%) | 30 (15.0) |
| Other,*n (%) | 123 (61.5) |
| Education | |
| Less than high school, n (%) | 132 (66.0) |
| High school/GED, n (%) | 40 (20.0) |
| Trade or vocational school, n (%) | 5 (2.5) |
| Some college, n (%) | 21 (10.5) |
| Prior knowledge of clinical trials, n (%) | 105 (54.4) |
| Prior participation in a clinical trial, n (%) | 34 (17.6) |
| Influenza vaccine in last year, n (%) | 150 (75.0) |
∗ Free response for “Other race” primarily included Latino/a, Dominican, Hispanic.